Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. FDA
Pharma
Roche's cancer med Gazyva scores FDA nod in lupus nephritis
With the lupus treatment landscape poised for a shake-up, Roche is hitting the scene with a new green light for its blood cancer drug Gazyva.
Fraiser Kansteiner
Oct 20, 2025 10:15am
Regulatory tracker: GSK's Shingrix gains China expansion
Oct 15, 2025 1:30pm
FDA drafts new policies to boost US drug production
Oct 3, 2025 3:52pm
How a government shutdown will affect the FDA
Oct 1, 2025 11:29am
FDA official chastises Aurinia med in now-deleted LinkedIn post
Sep 30, 2025 10:15am
Crinetics breaks commercial barrier with Palsonify FDA nod
Sep 25, 2025 5:30pm
